$NVRO
NEVRO CORP

2021 Q1 Form 10-Q Financial Statement

#000156459021024174 Filed on May 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $88.61M $87.47M
YoY Change 1.31% 6.47%
Cost Of Revenue $26.30M $26.90M
YoY Change -2.23% -7.05%
Gross Profit $62.30M $60.55M
YoY Change 2.9% 13.79%
Gross Profit Margin 70.31% 69.22%
Selling, General & Admin $73.27M $71.40M
YoY Change 2.62% -12.2%
% of Gross Profit 117.61% 117.93%
Research & Development $11.53M $12.21M
YoY Change -5.55% -13.6%
% of Gross Profit 18.51% 20.17%
Depreciation & Amortization $1.101M $1.296M
YoY Change -15.05% 19.45%
% of Gross Profit 1.77% 2.14%
Operating Expenses $84.81M $83.61M
YoY Change 1.43% -12.41%
Operating Profit -$22.51M -$23.07M
YoY Change -2.41% -45.41%
Interest Expense $6.547M $2.826M
YoY Change 131.67% 5.13%
% of Operating Profit
Other Income/Expense, Net -$457.0K $47.00K
YoY Change -1072.34% -113.7%
Pretax Income -$29.20M -$24.60M
YoY Change 18.7% -43.75%
Income Tax $300.0K $300.0K
% Of Pretax Income
Net Earnings -$29.56M -$24.89M
YoY Change 18.78% -43.53%
Net Earnings / Revenue -33.36% -28.45%
Basic Earnings Per Share
Diluted Earnings Per Share -$855.5K -$783.0K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $576.4M $247.5M
YoY Change 132.89% 3.3%
Cash & Equivalents $87.14M $137.3M
Short-Term Investments $489.9M $111.2M
Other Short-Term Assets $10.30M $8.400M
YoY Change 22.62% 2.44%
Inventory $85.81M $92.98M
Prepaid Expenses
Receivables $66.10M $64.70M
Other Receivables $0.00 $0.00
Total Short-Term Assets $738.7M $413.6M
YoY Change 78.6% 0.88%
LONG-TERM ASSETS
Property, Plant & Equipment $15.31M $11.16M
YoY Change 37.13% -69.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.400M $14.50M
YoY Change -69.66% 27.3%
Total Long-Term Assets $37.00M $46.40M
YoY Change -20.26% -3.56%
TOTAL ASSETS
Total Short-Term Assets $738.7M $413.6M
Total Long-Term Assets $37.00M $46.40M
Total Assets $775.7M $460.0M
YoY Change 68.63% 0.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $29.10M $19.90M
YoY Change 46.23% -13.76%
Accrued Expenses $42.24M $37.34M
YoY Change 13.13% -4.57%
Deferred Revenue
YoY Change
Short-Term Debt $171.0M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $246.4M $60.90M
YoY Change 304.6% -6.37%
LONG-TERM LIABILITIES
Long-Term Debt $144.0M $162.4M
YoY Change -11.33% 5.23%
Other Long-Term Liabilities $19.10M $2.050M
YoY Change 831.71% -91.67%
Total Long-Term Liabilities $163.1M $2.050M
YoY Change 7856.1% -98.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $246.4M $60.90M
Total Long-Term Liabilities $163.1M $2.050M
Total Liabilities $409.5M $244.9M
YoY Change 67.22% 11.63%
SHAREHOLDERS EQUITY
Retained Earnings -$522.4M -$434.7M
YoY Change 20.17%
Common Stock $651.1M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $366.2M $215.1M
YoY Change
Total Liabilities & Shareholders Equity $775.7M $460.0M
YoY Change 68.64% 0.41%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$29.56M -$24.89M
YoY Change 18.78% -43.53%
Depreciation, Depletion And Amortization $1.101M $1.296M
YoY Change -15.05% 19.45%
Cash From Operating Activities -$6.871M -$5.181M
YoY Change 32.62% -76.13%
INVESTING ACTIVITIES
Capital Expenditures $2.555M $830.0K
YoY Change 207.83% 43.1%
Acquisitions
YoY Change
Other Investing Activities $52.90M $61.12M
YoY Change -13.45% 516.13%
Cash From Investing Activities $50.34M $60.29M
YoY Change -16.51% 545.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.470M 16.18M
YoY Change -109.09% 811.95%
NET CHANGE
Cash From Operating Activities -6.871M -5.181M
Cash From Investing Activities 50.34M 60.29M
Cash From Financing Activities -1.470M 16.18M
Net Change In Cash 41.94M 70.92M
YoY Change -40.87% -771.49%
FREE CASH FLOW
Cash From Operating Activities -$6.871M -$5.181M
Capital Expenditures $2.555M $830.0K
Free Cash Flow -$9.426M -$6.011M
YoY Change 56.81% -73.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 nvro Employee Stock Purchase Plan Offering Period
EmployeeStockPurchasePlanOfferingPeriod
P6M
CY2020Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
168776000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11534000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12212000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
73272000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
71402000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
84806000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
83614000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-22512000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-23067000
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
297000
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1264000
CY2021Q1 us-gaap Interest Expense
InterestExpense
6547000
CY2020Q1 us-gaap Interest Expense
InterestExpense
2826000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-457000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
47000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1331000
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2801000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9235000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-29561000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
216352000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-29561000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-24888000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1101000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1296000
CY2021Q1 nvro Amortization Of Operating Lease Asset
AmortizationOfOperatingLeaseAsset
886000
CY2020Q1 nvro Amortization Of Operating Lease Asset
AmortizationOfOperatingLeaseAsset
826000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
9237000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8489000
CY2021Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-435000
CY2020Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
121000
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-831000
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
583000
CY2021Q1 us-gaap Inventory Write Down
InventoryWriteDown
1545000
CY2020Q1 us-gaap Inventory Write Down
InventoryWriteDown
432000
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4487000
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2071000
CY2021Q1 nvro Unrealized Gains And Losses On Foreign Currency Translation
UnrealizedGainsAndLossesOnForeignCurrencyTranslation
-1330000
CY2020Q1 nvro Unrealized Gains And Losses On Foreign Currency Translation
UnrealizedGainsAndLossesOnForeignCurrencyTranslation
126000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-12141000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-16912000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5639000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1863000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6153000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1436000
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-253000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
238000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5871000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4728000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1011000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-13937000
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-962000
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-781000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6871000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5181000
CY2021Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
147658000
CY2020Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
21851000
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
200555000
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
82975000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
830000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
60294000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1187000
CY2020Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
17365000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16178000
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-368000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
70923000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
137252000
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
159000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-83100000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1200000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6900000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-522400000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-492800000
CY2020Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1868750
CY2020Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
147100000
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-1452000
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
215000
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
1002000
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-150000
CY2021Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
6900000
CY2020Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
17600000
CY2021Q1 nvro Bad Debt Recovery
BadDebtRecovery
100000
CY2020Q1 nvro Bad Debt Expense
BadDebtExpense
600000
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y25D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M25D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.070
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.070
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3826000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5258000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5522000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5688000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2399000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
22693000
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3027000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
19666000
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
534390000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
543246000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
152000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
25000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
543373000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1234000
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1234000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17256000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18142000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3967000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3876000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15699000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16689000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
19666000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
20565000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1248000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1210000
CY2021Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
22900000
CY2020Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
16300000
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
534410000
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
84000
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
104000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
495416000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
495384000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
38994000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
39006000
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
534410000
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
534390000
CY2021Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
33719000
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
34405000
CY2021Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
52094000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
48891000
CY2021Q1 us-gaap Inventory Net
InventoryNet
85813000
CY2020Q4 us-gaap Inventory Net
InventoryNet
83296000
CY2021Q1 nvro Inventory Write Down Cash And Non Cash
InventoryWriteDownCashAndNonCash
1500000
CY2020Q1 nvro Inventory Write Down Cash And Non Cash
InventoryWriteDownCashAndNonCash
400000
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
34180000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
31304000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18875000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17773000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15305000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13531000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1101000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1296000
CY2020Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
418000
CY2021Q1 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
851000
CY2020Q1 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
1192000
CY2020Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
26417000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
30971000
CY2021Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4964000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2101000
CY2021Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
917000
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1191000
CY2021Q1 nvro Accrued Clinical And Research Expenses Current
AccruedClinicalAndResearchExpensesCurrent
483000
CY2020Q4 nvro Accrued Clinical And Research Expenses Current
AccruedClinicalAndResearchExpensesCurrent
668000
CY2021Q1 us-gaap Interest Payable Current
InterestPayableCurrent
3607000
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1548000
CY2021Q1 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
851000
CY2020Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
699000
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4999000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6127000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
42238000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
43305000
CY2021Q1 us-gaap Standard Product Warranty Description
StandardProductWarrantyDescription
limited one- to five-year warranty
CY2020Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
699000
CY2019Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
1178000
CY2021Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
695000
CY2020Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
432000
CY2021Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
543000
CY2021Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-29561000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-24888000
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34633749
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
31839812
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.85
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.78
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9156363
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6102632
CY2021Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
2200000
CY2020Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
2100000

Files In Submission

Name View Source Status
0001564590-21-024174-index-headers.html Edgar Link pending
0001564590-21-024174-index.html Edgar Link pending
0001564590-21-024174.txt Edgar Link pending
0001564590-21-024174-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nvro-10q_20210331.htm Edgar Link pending
nvro-10q_20210331_htm.xml Edgar Link completed
nvro-20210331.xsd Edgar Link pending
nvro-20210331_cal.xml Edgar Link unprocessable
nvro-20210331_def.xml Edgar Link unprocessable
nvro-20210331_lab.xml Edgar Link unprocessable
nvro-20210331_pre.xml Edgar Link unprocessable
nvro-ex311_6.htm Edgar Link pending
nvro-ex312_7.htm Edgar Link pending
nvro-ex321_8.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending